Prescribing and clinical use
Focused clinical detail for use alongside current product information, local policy and patient-specific assessment.
Clinical details
Prescribing considerations
- Confirm that a bacterial pathogen is documented or sufficiently likely to be susceptible; amoxicillin alone is unreliable against beta-lactamase-producing organisms.
- Take a detailed history of reactions to penicillins, cephalosporins and other beta-lactams before treatment; distinguish intolerance or a nonspecific rash from a confirmed immediate allergy.
- Base dose selection on infection site and severity, expected pathogen, age, weight and renal function.
- Avoid amoxicillin when infectious mononucleosis is suspected because a morbilliform rash is strongly associated with its use; such a rash is not by itself proof of lifelong penicillin allergy.